Genetics

A recent genetic study investigates whether metabolic changes observed in multiple sclerosis (MS) may actively contribute to disease severity rather than merely reflect disease progression. Using metabolome-wide Mendelian randomization, genetic colocalization, and cis-MR analyses, the researchers identified several lipid and amino-acid pathways associated with MS severity, with particularly strong evidence implicating polyunsaturated fatty-acid metabolism. The findings highlight FADS1 as a central regulator, showing that genetically predicted reductions in FADS1 activity and expression are associated with greater MS severity in both circulating metabolic profiles and specific brain cell types. Additional evidence involving CYP4F2 further supports a role for altered PUFA metabolism. Although the study is a preprint and requires further experimental and clinical validation, it provides a compelling mechanistic framework for understanding why MS progression varies substantially among individuals.